Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Dr. David Koren Explains the Impact of Antiretroviral Therapy Stewardship Teams

View All News

David Koren, PharmD, BCPS, AAHIVP, Clinical Pharmacist Specialist in Infectious Diseases at Temple University Hospital, Adjunct Assistant Professor in the Department of Medicine at the Lewis Katz School of Medicine at Temple University and Adjunct Clinical Assistant Professor in the Department of Pharmacy Practice at Temple University School of Pharmacy, was interviewed by Healio’s Infectious Disease News about a retrospective cohort study he was part of that looked at the effect of antiretroviral therapy (ART) stewardship teams. Dr. Koren and the research team found that the program improved patient safety and care and saved money. The stewardship teams included an HIV pharmacist specialist, infectious diseases physicians and “associated learners.” The findings were published in Open Forum Infectious Diseases.